secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0000950170-23-027254
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology 2023 annual meeting results; all director nominees elected, auditor ratified
--------------------------------------------------------------------------------

- Hans E. Bishop elected Class II director with 108,928,064 votes for, 19,856,165 withheld.
- Robert Nelsen elected Class II director with 111,403,976 votes for, 17,380,253 withheld.
- Alise S. Reicin, M.D. elected Class II director with 110,664,981 votes for, 18,119,248 withheld.
- Ratification of Ernst & Young as auditor for FY2023 approved: 142,770,600 for, 184,749 against, 125,243 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000095017023027254/0000950170-23-027254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000095017023027254/sana-20230608.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer